图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:CLINICAL INFECTIOUS DISEASES

ISSN:1058-4838
版本:SCI-CDE
出版频率:Semi-monthly
出版社:OXFORD UNIV PRESS INC, JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513
  出版社网址:http://www.oxfordjournals.org/
期刊网址:http://cid.oxfordjournals.org/
影响因子:9.079
主题范畴:IMMUNOLOGY;    INFECTIOUS DISEASES;    MICROBIOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Inaugurated in 1979 to complement JID, this journal publishes state-of-the-art clinical articles, including those in microbiology; a regular AIDS/TB Commentary; sections covering medical and legal issues and managed care symposia; time-saving review articles, which survey the growing body of research literature in a specific area or on a group of related topics; and thematic studies on central topics in infectious disease research.

Frequency: semi-monthly, two volumes/year, twelve issues/volume. Volume 36 begins January 1, 2003. ISSN: 1058-4838. 160 pages/issue.


Instructions to Authors
 

GENERAL INFORMATION

     Authors may now submit their manuscripts online and are encouraged to do so. For instructions, see Manuscript Submission, below.

     Clinical Infectious Diseases (CID) is published under the auspices of the Infectious Diseases Society of America (IDSA). The scope of the journal includes pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, HIV/AIDS, and the treatment of diseases caused by infectious agents. CID publishes clinically relevant articles of current interest in these areas and also invited minireviews in the following Special Sections: Aging and Infectious Diseases, Antimicrobial Resistance, Clinical Practice, Confronting Biological Weapons, Emerging Infections, Food Safety, Healthcare Epidemiology, HIV/AIDS, Immunocompromised Hosts, Medical Microbiology, Reviews of Anti-Infective Agents, Surfing the Web, Travel Medicine, and Vaccines, as well as book reviews, photo quizzes, arcana, and news.

Policies

     Evaluation of manuscripts.     All newly submitted manuscripts are read by the Editor and the Deputy Editor, who reject outright approximately one-third of unsolicited articles. All other manuscripts are sent to outside experts for review. The manuscript and reviews are evaluated by an Associate Editor, who recommends that the Editor accept or reject the manuscript or return it to the authors for revision. A request for revision does not guarantee that the article will be accepted.

     Duplicate publication.     CID does not publish articles that overlap substantially with articles already published or accepted for publication, whether in print or in the electronic media, even if the new submission contains data not included in the published or accepted work. CID's policy is governed by international copyright laws, ethical conduct, and the cost-effective use of resources. Readers of primary-source periodicals deserve to be able to trust that what they are reading is original, unless there is a statement that the article is being republished by the choice of the author and Editor. This policy does not preclude consideration of a report that (1) follows a presentation at a meeting, (2) expands preliminary findings published or presented as an abstract, or (3) has been rejected by another journal. An article that the author thinks overlaps substantially with the manuscript submitted for review should be included with the submission. If an attempt at undisclosed duplicate publication is revealed, the article will be rejected, the owners of the copyright will be notified, and the violation may be reported to the Publications Board of the IDSA, depending on the circumstances. If duplicate publication does occur without the express, written permission of the Editor, a notice of the duplication may be published in CID, and additional steps may be taken at the Editor's discretion. Release of preliminary reports to the media, government agencies, or manufacturers of scientific products described in a paper that has been accepted, but not yet published, violates CID policy. Release of these reports may be warranted when they pertain to issues of urgent public importance, but they may be released only if there is express, written permission from the Editor.

     Conflict of interest.     There is a conflict of interest when anyone involved in the publication process has ties to activities that could influence his or her judgment, whether or not judgment is, in fact, affected. Authors must disclose financial and other potential conflicts of interest that might have biased their work, and, in a footnote to the title page, acknowledge the financial support they have received or anticipate receiving. In the cover letter to the Editor, the corresponding author should state, on behalf of all the authors, that all potential conflicts of interest have been disclosed. Reviewers also should disclose any conflicts of interest that could bias their opinions of the manuscript and should offer to disqualify themselves from review. In addition, reviewers must not use their prepublication knowledge of the article to further their own interests.

     Human and animal experimentation.     When reporting experiments on human subjects, indicate in the Methods section whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials, or hospital numbers, in text or in illustrative material. Also state in the Methods section the manner in which informed consent was obtained from the subjects. When reporting experiments on animals, indicate in Methods whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. (See International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Ann Intern Med 1997; 126:3647.)

Categories of Articles

     Papers may be submitted in the following categories; note that the category may subsequently be changed by the Editors for consistency with CID style.

     Major Articles are uninvited articles that report clinically relevant investigations or observations within CID's scope of interests. The abstract should not exceed 150 words, the text should not exceed 3000 words, and there should be approximately 30 references. Figures and tables may be included as needed; however, data should not be repeated in both a table and a figure.

     Brief Reports are condensed articles with a focused message. They should include a brief abstract of no more than 50 words, a text of no more than 1500 words, 10-12 references, and 1 table or figure. Case reports are considered Brief Reports and have the same length requirements; they report a single case or several cases and give a concise review of the literature. Case reports should present unusual aspects of common problems or novel perspectives upon, or solutions to, clinically relevant issues.

     Review Articles are reviews of topics related to clinical aspects of infectious diseases. The text should not exceed 3000 words, and the abstract should not exceed 150 words.

     Viewpoints are articles that present the opinions of the authors rather than new experimental data or literature reviews. They should include an abstract of no more than 150 words and a text of no more than 3000 words.

     Editorials and Editorial Commentaries are usually invited articles, but unsolicited articles of an editorial nature that relate or respond to articles published in CID will also be considered.

     Special Sections contain articles that address areas of particular interest to CID and, with the exception of most articles in the HIV/AIDS section, are solicited by the Special Section Editors from experts in each area. CID's Special Sections are listed under General Information, above.

     Photo Quizzes are question-and-answer articles that illustrate an unusual illness and that invite a diagnosis from the reader. In the question portion, you may state the history of the case, noting the findings and the outcome, but do not divulge the diagnosis by revealing details of the treatment; state only whether treatment was successful. The quiz should be written in a single paragraph and accompanied by no more than 3 glossy color prints. The answer to the quiz should give the diagnosis and a brief overview of the illness, emphasizing its particular features. If additional illustrations are needed for the answer, provide black-and-white glossy prints, with arrows marking their key elements. See Manuscript Submission, below, for details on submission of Photo Quizzes.

     Arcana are meant to entertain and educate the CID readers by presenting some unusual detail about the practice of infectious diseases. An Arcanum may be accompanied by photographs. For more detailed information on how to prepare these articles, refer to the Manuscript Preparation section; to submit an Arcanum, see Manuscript Submission, below.

     Correspondence should not exceed 500 words and should pertain to articles or letters published previously in CID or should address an issue of interest to CID readers. Replies should be no more than 500 words and will be published in the same issue as the letter.

     Book Reviews are invited. Publishers should send 2 copies of their book to the CID office for review. Not all books received are reviewed.

Supplements

     CID publishes supplements on topics related to its scope of interests as defined above. They may be proceedings of a symposium or the results of a study and are sponsored by universities, organizations, drug companies, and grants. The topic, table of contents, and guest editor(s) must be approved by the Editor. Supplement articles are sent for initial peer review by the guest editor and are revised under the guest editor's supervision before being submitted in toto to the CID editorial office. There, all articles are again peer reviewed by experts chosen by the CID Editors. The author of an article submitted under his or her name by a third party (e.g., the guest editor, a commercial editing service, or the sponsor of the supplement) has sole responsibility for the contents of that article. Inquiries related to suitability of topic, program organization, and production should be made in writing to the Editor.

Revisions

     The deadline for submission of revised manuscripts is 60 days after the decision date. On the upper right-hand corner of the title page, note the original manuscript number and the word "Revision". Unless the decision letter or the reviews specifically indicate otherwise, it is essential not to increase the length of the manuscript or it may be returned to you again to be shortened. The cover letter should include a point-by-point response to the reviews and to the criticisms with which you disagree and should indicate any additional changes you have made. You will also receive a Publication Agreement and a form for Disclosure of Conflict of Interest, both of which should be completed, signed and dated, and returned with the revision. Signing these forms in no way guarantees that your article will be accepted for publication.

Print and Electronic Publication

     All accepted articles are published in the electronic edition of CID and are indexed in MEDLINE, and most are published in the print edition also. Because of CID's page limitations, however, some articles are accepted for electronic publication only. In such cases, authors are given the opportunity to withdraw their papers. Articles published only electronically are listed in the print issue, including the title, all authors, and a short abstract, and are also indexed in MEDLINE. The entire article is made available in the electronic edition of CID, with free access to the full text. There are no page charges for electronic-only publication.

Proofs

     CID reserves the right to edit for clarity, conciseness, grammar, and journal style. Authors review editing changes at the proof stage but must limit their alterations in proof to correcting errors and clarifying misleading statements. The publisher will notify the corresponding author when the proofs are available on the publisher's Web site and will include instructions on how to download proofs and make corrections. Proofs must be returned to the publisher within 48 hours of receipt to prevent delay in publication.

Charges

     Proofs.     Authors will be charged for alterations other than those made to correct errors or misleading statements.

     Reprints.     A reprint order form and an invoice for page charges will accompany the proofs.

     Page charges.     The page charges are $55 for each of the first 6 pages and $85 for each subsequent page. The Editors, at their discretion, may waive these charges. Invited articles, correspondence, and articles published only in the electronic edition are exempt from charges.

     Color figures.     Authors are charged for the reproduction of color figures. For the first page, the cost is $500, and for each additional page, $400. If 2 or more figures can be placed on a single page, the cost for that page is $500. Authors should state in their cover letter whether they will bear the cost of reproducing their color figures, or if they prefer to have them published in black and white at no additional cost.

DOCUMENT REQUIREMENTS

Manuscript Preparation

     The Editors reserve the right to request that manuscripts not conforming to the following instructions be rewritten.

     Manuscripts should be double spaced throughout, including the references and the table and figure legends, with margins of 1 inch on each side. Number all pages, except for the figures, with the title page as page 1, noted in the lower right-hand corner of the page. Each section of the article should begin on a separate page, as follows: title page, abstract, text, acknowledgments, references, tables, figure legends, and figures.

     Title page.     All manuscripts, including Correspondence, should have a title page that includes the following information: (1) a concise, informative title; (2) the names and affiliations of all authors; (3) 5 keywords; (4) a short title of no more than 40 characters and spaces; (5) a footnote indicating all sources of financial support (see Conflict of Interest, under Policies, above); (6) the name, mailing address, telephone and fax numbers, and e-mail address of the corresponding author, if there is more than one author; and (7) the same contact information for an alternate corresponding author, in the event that the corresponding author cannot be reached.

     Abstract.     All articles, except Editorials, Correspondence, Photo Quizzes, and Brief Reports, should have an unstructured abstract of not more than 150 words. The first sentence should state the problem being addressed, and the last sentence the conclusions. For Brief Reports, only a brief abstract (50 words) that summarizes the report is acceptable.

     Text.     Authors are encouraged to follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. They should strive for a concise article that is unencumbered by excessive detail (word limits are specified under Categories of Articles, above). All but the shortest articles should have subheadings. The use of abbreviations is discouraged except for standard measurements; if needed, however, abbreviations other than units of measure may be used but should appear in parentheses the first time they are used in the textfor example, computed tomography (CT).

     Style.     Authors are referred to the American Medical Association Manual of Style: A Guide for Authors and Editors (9th ed., Williams & Wilkins, 1997) and the Chicago Manual of Style (14th ed., University of Chicago Press, 1993).

     For commercially obtained products mentioned in the text, list full names of manufacturers. Generic names of drugs and other chemical compounds should be used.

     Nomenclature.     CID attempts to use the latest widely accepted nomenclature. See Bergey's Manual of Determinative Bacteriology (9th ed., revised, Williams & Wilkins, 1993) and Enzyme Nomenclature 1992: Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes (Academic Press, 1992). Formal terms for virus families, genera, and species should be those approved by the International Committee on Taxonomy of Viruses: Virus TaxonomyThe Classification and Nomenclature of Viruses: Sixth Report of the International Committee on Taxonomy of Viruses (Springer-Verlag, 1995). This volume also includes standard abbreviations for virus species. For names and abbreviations of chemical compounds, refer to the Merck Index (12th ed., Merck, 1996). The Editors appreciate the assistance of authors and readers who inform them of changes in nomenclature.

     Statistical analysis.     The statistical analyses used should be identified both in the text and in all tables and figures where the results of statistical comparison are shown.

     Units of measurement.     The use of SI units is encouraged. All data should be expressed in metric units. Use degrees Celsius for temperature.

     Acknowledgments.     The names of those who assisted the authors should be noted on a separate page preceding the references.

     References.     CID reference style is based on that used by the National Library of Medicine in Index Medicus; names of journals are abbreviated according to the List of Journals Indexed in Index Medicus.Titles of journals not listed in Index Medicus should be spelled out in full. Number references consecutively as they appear in the text, with the numbers in brackets and on the text line (e.g., [3, 79, 57]). References first mentioned in tables or figures should be cited to be in sequence with those in the text. For example, if table 1 is cited in the text after reference [8], the next new reference in table 1 will be reference [9]. Only references that have been published or that are in press (i.e., accepted for publication) are to be included in the reference list. Unpublished observations (authors' unpublished data), personal communications (G. J. Rudy, personal communication), and manuscripts in preparation or submitted for publication (H. Chapin and J. Banashak, submitted) but not yet accepted should not appear in the reference list but should be noted parenthetically in the text, with all authors listed (see also Permissions, under Supporting Documents, below).

     In the reference list, if a reference has 6 authors or fewer, all authors should be listed. If there are 7 authors or more, list the first 3 authors, followed by "et al." Reference to a doctoral dissertation should include the author, title, institution, location, year, and publication information, if published. For online resources, include a URL and date accessed. Accuracy of references is the responsibility of the authors.

     Examples of the proper format are as follows:

  1. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155:117784.

  2. McIntosh K. Diagnostic virology. In: Fields BN, Knipe DM, Chanock RM, et al., eds. Fields virology. 2nd ed. Vol 1. New York: Raven Press, 1990:41140.

  3. Soriano A, Martinez A, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30:36873.

  4. Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995:46578.

  5. Centers for Disease Control and Prevention. Revised classification system for HIV infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43:110.

  6. World Health Organization (WHO). Health aspects of chemical and biological weapons. 2nd ed. Geneva, Switzerland: WHO [in press].

  7. Lyon DJ, Cheng AFB, Norrby SR. Mechanisms of cefotaxime resistance in blood culture isolates of Enterobacter high prevalence of extended-spectrum -lactamases [abstract C43]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995:47.

  8. Public Health Service Task Force. Recommendations for the use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Available at: http://www.aidsinfo.nih.org. Accessed 24 April 2002.

     Tables.     Tables should be included in the manuscript file, double spaced, each on a separate page, and numbered consecutively, with a descriptive title and no vertical lines. In a footnote to the table, define all abbreviations used, other than units of measure. Footnotes and accompanying explanatory material should be kept to a minimum. Footnotes should be placed below the table and designated by superscript lowercase letters (listed in order of location when the table is read horizontally). Each column must have a heading describing the data in the column below, and units of measure must be clearly indicated. For further instructions on the preparation of tables in Word or WordPerfect, consult the Special Instructions for Tables.

     Figure legends.     Figure legends should be double spaced and should appear on a separate page preceding the figures. Any abbreviations or symbols used but not defined in the figure itself must be defined in the legend.

     Figures.          Figures should be also numbered in the order of mention in the text. Please prepare your figures in accordance with the Guidelines for Submission of Artwork. Letters, numbers, and symbols should be clear and of sufficient size to be legible when the figures are reduced. Photomicrographs should have internal scale markers. Figures reproduced from other publications must be accompanied by permission from the copyright holder.

Supporting Documents

     Cover letter.     A cover letter must be included with all manuscripts submitted to CID, noting the name, address, telephone and fax numbers, and e-mail address of both the corresponding author an alternate author who can receive proofs if the corresponding author is unavailable. The letter should warrant that all authors have seen and approved the manuscript, that they have contributed significantly to the work, and that the manuscript has not been published and is not being considered for publication elsewhere. The corresponding author should state, on behalf of all the authors, that all potential conflicts of interest have been disclosed. Authors are asked to provide the names of 3 or 4 potential unbiased reviewers and their complete contact information. They may also note the names of reviewers whom they do not want to review their manuscript. Authors should state in their cover letter whether they will bear the cost of reproducing their color figures (see Charges) or whether they prefer to have them published in black and white at no additional cost. A cover letter must also accompany a revised submission and must address issues raised in the review process.

     Related manuscripts.     Include a copy of any closely related manuscript submitted to or published in CID or elsewhere. If there appears to be significant overlap, the Editor will ask the corresponding author to respond to the question of overlap. (For more information, see Duplicate Publication, under Policies, above.)

     Permissions.     Obtain written permission from the copyright holder to reproduce unpublished or previously published articles, tables, or figures from another source. For published articles, the copyright holder is usually the publisher, not the author, except for articles in the public domain. The copyright holder of unpublished papers is the author. Written permission must be obtained from all investigators cited in a personal communication who are not coauthors of the present manuscript. All permissions should be submitted with the manuscript.

     Nucleotide sequences.     Nucleotide sequences must be submitted to the International Nucleotide Sequence Databases prior to acceptance, and the accession numbers must appear in the final revision of the manuscript. Please visit http://www.ncbi.nlm.nih.gov/Genbank, http://www.ebi.ac.uk/embl, and http://www.ddbj.nig.ac.jp for more information.

MANUSCRIPT SUBMISSION

     Authors are encouraged to submit their manuscripts via the CID Web Peer Review system at http://mss.uchicago.edu/CID. Detailed instructions are available below. If submission by means of the Web interface is not possible, please click here for instructions on how to submit a hard copy of your manuscript.

     Photo Quizzes and Arcana should be submitted directly to Philip A. Mackowiak, M.D., Medical Services (111), VA Medical Center, 10 N. Greene St., Room 5D143, Baltimore, MD 21201, USA (philip.mackowiak@med.va.gov).

Formatting Electronic Files

     Please follow the requirements below to submit a new or revised manuscript via the Web Peer Review system. The system relies on automated processing to create an Adobe Acrobat (PDF) file from your submission. If you do not follow these instructions, your submission cannot be processed automatically and will not be received by the journal office.

Acceptable formats
  • Microsoft Word (.docany version that can be read by Word 2000 for Windows)

  • Rich Text Format (.rtf)

     File contents.     Manuscripts should be submitted as single files with all figures, tables, and images embedded (inserted) directly into the document. Consult your word processing program's "Help" documentation for instructions on how to embed tables and figures. If necessary, you may submit images as separate files in .jpg, .tif, .eps, or .gif format. You must also submit a cover letter in a second file, in the same format as your main file or else as plain text (an ASCII file). Follow the instructions listed above for manuscript, table, and figure preparation.

     Videos must be submitted in the MPEG or Quicktime format. For each video, please submit a still image captured from the MPEG or Quicktime file; this will appear as a printable figure with the article. A video must have a legend, as well, that will appear with the still image. If you wish to submit a video, please consult with the CID editorial office for further details.

     Filename requirements.     All filenames must be lowercase. (All file processing by the Web Peer Review system is done on Unix machines, where filenames are case-sensitive). Filenames must conform to the specifications given in the table below.


Main text file Cover letter Figures Tables
Word ms.doc cover_letter.doc or cover_letter.txt [embedded in ms.doc] [embedded in ms.doc]
RTF ms.rtf cover_letter.rtf or cover_letter.txt [embedded in ms.rtf] [embedded in ms.rtf]

     File compression and archives.     We strongly recommend that you make an archive of all the files for your submission and then upload the single archive file. Applications for Mac OS (such as StuffIt) and Windows (such as WinZip) support the formats listed below.

     The following archive formats may be used:

  • Windows or Unix zip (e.g., "archive.zip")

  • Unix tar (e.g., "archive.tar" or compressed with gzip as "archive.tar.gz" or "archive.tgz")

     If you cannot create archives in these formats, you may still compress invididual files to shorten upload time:

  • Unix compress (e.g., "ms.tex.Z")

  • Unix gzip (e.g., "ms.tex.gz")

     Revisions.     If you are submitting a revised manuscript, include your response to the reviewers' comments as part of the cover letter file. When submitting a revised manuscript with figures, include all the figures even if they have not changed since the previous version.

Online Submission Instructions

     Preparing the manuscript file.     The preferred format for submitting manuscripts online is Microsoft Word (.doc files). If you are unable to submit a Microsoft Word file, the Web Peer Review system will also accept manuscripts in Rich Text Format (.rtf). We have provided a drop box in the "File format" area in which to indicate the document type.

     As mentioned above, manuscripts should be submitted as single files with all figures, tables, and images embedded (inserted) directly into the document. If necessary, you may submit images as separate files in .jpg, .tif, .eps, or .gif format. Please note that authors whose manuscripts are accepted for publication may be required to submit high-resolution hard copies (e.g., glossy prints) after the review process is complete and press production is about to begin.

     Submission checklist.     Please have the following items readily available before beginning the online submission process:

  • Your manuscript as an MS Word, Rich Text, or AASTex fileincluding all tables, figures and images embedded in the document

  • Information from your title page: title, list of contributing authors and affiliations, word count, and contact information for the corresponding author

  • A list of recommended reviewers

Navigating the Peer Review Web Site

     Step One: Describing your manuscript

     Go to the CID Peer Review Web site at http://mss.uchicago.edu/CID. A username and password are required to enter the site. If you already have a username and password, click on "Login/See current tasks" to view the status of your account. If you are new to the site, click on "Create account" to register. After completing your login, click on the "Begin submission" button.

     Once you have logged in, fill in the fields describing your manuscript. To move from one field to the next, press the "tab" key. When all the information is complete and you are sure it is correct, click "Ready to upload files" to proceed to step two.

     Step Two: Uploading your file(s)

     Click the "Browse" button to locate a file on your local system. Once a file is specified in the field, click "Upload this file" to send the file to the Web Peer Review system. You must name your manuscript file "ms", using lowercase type. (All file processing by the Web Peer Review system is done on Unix machines, where filenames are case-sensitive.) The system will rename your manuscript with a manuscript ID number during the upload.

     As previously mentioned, your manuscript file must contain all figures and tables as well as the text. Remember that if you have multiple files, you can compress all of them into a single archive and upload just one file. We recommend that you make an archive of all the files for your submission and then upload the single archive file. See the Formatting Electronic Files section for detailed instructions.

     Check your results. Only files listed in the box labeled "Files uploaded so far" have been uploaded successfully. If you need to delete a file, click the file name in the box to select it, and then click the "Delete selected file" button.

     When you have uploaded all the files for your submission, click "Process uploaded files" to proceed. The system will attempt to make a PDF version of your file. The conversion to PDF reduces the size of the file and makes it easier for Editors and reviewers to read. PDF files can be viewed with Adobe Acrobat Reader version 3 or higher (available free at http://www.adobe.com) or with Ghostscript 5.1 or higher compiled with PDF support turned on (available free at http://www.cs.wisc.edu/~ghost). If successful, there will be a link to the PDF on the next Web page that appears.

     If you want to delete all the uploaded files and make no submission, click "Cancel submission" instead.

     Step Three: Submitting your information

     After your file has been converted to a PDF, view the file that was generated from your submission by clicking on "ms.pdf" (a link that will be provided on the next Web page that appears). After you finish viewing the PDF, indicate how you would like to proceed.

     If you select "Approve and submit now," you assert that you have viewed the PDF file via the link provided and that the file accurately shows your manuscript as reviewers should see it. If you select "Fix and resubmit later," the files you have already uploaded will be saved (for 30 days) so that you can return later and upload new or corrected files to make a new PDF file.

     Click "Finish" to complete the final process. Click "Cancel" if you wish to abort the submission.

     If your manuscript has been successfully submitted to the CID Web Peer Review system, a confirmation screen, which includes your assigned manuscript number, will appear. Please carefully note this number and use it in all future correspondence with the CID editorial office. An e-mail message confirming your submission will be sent to you.

     If you do not receive either a manuscript number or confirmation e-mail, your manuscript was not successfully submitted to the journal and thus cannot be sent on to peer review. Please try again or contact cid-help@mss.uchicago.edu for assistance.

     Submit your manuscript now: http://mss.uchicago.edu/CID.


Editorial Board

Editor

Submissions and communications for the editor should be addressed to:

Clinical Infectious Diseases
Tufts University School of Medicine
136 Harrison Avenue
Boston, Massachusetts 02111

Telephone: (617) 636-2780; Fax: (617) 636-4060

 E-mail: cid@press.uchicago.edu

 E-mail: sherwood.gorbach@tufts.edu



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有